Long ZD, Yu X, Xing ZX, Wang R. Multiparameter magnetic resonance imaging-based radiomics model for the prediction of rectal cancer metachronous liver metastasis. World J Gastrointest Oncol 2025; 17(1): 96598 [DOI: 10.4251/wjgo.v17.i1.96598]
Corresponding Author of This Article
Rui Wang, MD, Doctor, Department of Hepatobiliary and Pancreaticosplenic Surgery, Jingzhou Hospital Affiliated to Yangtze University, No. 26 Chuyuan Road, Jingzhou District, Jingzhou 434100, Hubei Province, China. hyhq0216@163.com
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Retrospective Cohort Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastrointest Oncol. Jan 15, 2025; 17(1): 96598 Published online Jan 15, 2025. doi: 10.4251/wjgo.v17.i1.96598
Multiparameter magnetic resonance imaging-based radiomics model for the prediction of rectal cancer metachronous liver metastasis
Zhi-Da Long, Xiao Yu, Zhi-Xiang Xing, Rui Wang
Zhi-Da Long, Xiao Yu, Zhi-Xiang Xing, Rui Wang, Department of Hepatobiliary and Pancreaticosplenic Surgery, Jingzhou Hospital Affiliated to Yangtze University, Jingzhou 434100, Hubei Province, China
Author contributions: Wang R designed the research study; Long ZD has completed the preliminary data collection and visualization analysis; Yu X and Xing ZX have completed the initial draft and proofreading of their paper; All authors have made final corrections to the manuscript.
Institutional review board statement: This study has been approved by the Ethics Committee of Jingzhou Central Hospital and complies with the Helsinki Declaration. All included patients were exempt from informed consent, No. 2024-154-01.
Informed consent statement: As the study only involved retrospective chart reviews, informed written consents were not required in accordance with institutional IRB policy.
Conflict-of-interest statement: The authors declare that they have no conflict of interest.
Data sharing statement: Not applicable.
STROBE statement: The authors have read the STROBE Statement—a checklist of items, and the manuscript was prepared and revised according to the STROBE Statement-a checklist of items.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Rui Wang, MD, Doctor, Department of Hepatobiliary and Pancreaticosplenic Surgery, Jingzhou Hospital Affiliated to Yangtze University, No. 26 Chuyuan Road, Jingzhou District, Jingzhou 434100, Hubei Province, China. hyhq0216@163.com
Received: May 10, 2024 Revised: September 6, 2024 Accepted: September 27, 2024 Published online: January 15, 2025 Processing time: 215 Days and 20.5 Hours
Core Tip
Core Tip: In recent years, with the rapid development of data and information technology, imaging omics has been gradually applied in the clinical diagnosis and treatment of tumors, as it can non-invasive extract high-throughput heterogeneity information within tumors and integrate patient clinical information to improve the accuracy of models. Up to now, imaging omics models based on computed tomography or magnetic resonance imaging (MRI) images have shown potential application value in preoperative T and N staging and efficacy evaluation of rectal cancer. However, there is currently very little imaging omics research based on MRI of primary rectal cancer tumors. In fact, MRI is the most accurate imaging method for diagnosing rectal cancer, which can better display the invasion of adjacent lymph nodes, blood vessels, or surrounding organs by primary rectal cancer tumors. In view of this, this study attempts to establish a non-invasive preoperative prediction model for metachronous liver metastasis in rectal cancer based on the imaging omics features of the initial diagnosis MRI images of rectal cancer, combined with machine learning algorithms, and verify its effectiveness. This will provide clinical assistance for clinicians to make personalized monitoring and treatment decision.